Verve Therapeutics Inc (VERV) Insider Trading
- $958,478.00
- $33,860,887.32
- May 14, 2024
- Andrew Bellinger
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 14, 2024 | Insider | 76,000 | $6.26 | Buy | $475,760.00 | |
April 2, 2024 | Insider | 1,514 | $8.24 | Sell | $12,475.36 | |
Nov. 29, 2023 | CFO | 554 | $11.45 | Sell | $6,343.30 | |
Dec. 1, 2022 | CMO | 865 | $22.95 | Sell | $19,851.75 | |
Nov. 29, 2022 | CFO | 554 | $22.10 | Sell | $12,243.40 | |
Nov. 4, 2022 | Major Shareholder | 97,166 | $31.14 | Sell | $3,025,749.24 | |
Nov. 3, 2022 | Director | 49,568 | $32.79 | Sell | $1,625,334.72 | |
Nov. 2, 2022 | Major Shareholder | 57,303 | $35.94 | Sell | $2,059,469.82 | |
Oct. 31, 2022 | Director | 53,696 | $38.64 | Sell | $2,074,813.44 | |
Oct. 31, 2022 | Major Shareholder | 107,393 | $38.64 | Sell | $4,149,665.52 | |
Oct. 28, 2022 | CMO | 10,000 | $39.90 | Sell | $399,000.00 | |
Oct. 3, 2022 | CEO | 50,000 | $33.65 | Sell | $1,682,500.00 | |
Sept. 23, 2022 | CMO | 60,000 | $35.34 | Sell | $2,120,400.00 | |
Aug. 10, 2022 | CEO | 50,000 | $29.90 | Sell | $1,495,000.00 | |
July 20, 2022 | CMO | 20,000 | $34.90 | Sell | $698,000.00 | |
July 19, 2022 | CEO | 50,000 | $29.90 | Sell | $1,495,000.00 | |
July 13, 2022 | CMO | 10,000 | $24.90 | Sell | $249,000.00 | |
July 13, 2022 | CSO & CMO | 10,000 | $24.90 | Sell | $249,000.00 | |
July 12, 2022 | N/A | 100,000 | $19.98 | Sell | $1,998,000.00 | |
July 1, 2022 | Insider | 38,775 | $15.66 | Sell | $607,216.50 | |
June 29, 2022 | Insider | 34,409 | $15.59 | Sell | $536,436.31 | |
May 12, 2022 | Director | 10,000 | $12.15 | Buy | $121,500.00 | |
March 15, 2022 | Director | 4,000 | $21.38 | Buy | $85,520.00 | |
March 9, 2022 | Insider | 3,971 | $29.01 | Sell | $115,198.71 | |
Feb. 9, 2022 | Insider | 13,190 | $29.46 | Sell | $388,577.40 | |
Feb. 1, 2022 | Insider | 35,574 | $29.04 | Sell | $1,033,068.96 | |
Jan. 26, 2022 | Insider | 149,853 | $31.23 | Sell | $4,679,909.19 | |
Jan. 4, 2022 | CEO | 1,870 | $39.90 | Sell | $74,613.00 | |
Dec. 28, 2021 | CEO | 6,693 | $39.90 | Sell | $267,050.70 | |
Dec. 22, 2021 | Insider | 15,000 | $38.70 | Sell | $580,500.00 | |
Dec. 22, 2021 | CEO | 57,000 | $38.71 | Sell | $2,206,470.00 | |
Dec. 2, 2021 | Director | 4,700 | $31.34 | Buy | $147,298.00 | |
Dec. 2, 2021 | Insider | 4,000 | $32.10 | Buy | $128,400.00 |
Insiders are both buying and selling Verve Therapeutics Inc stock.
The insider traders at Verve Therapeutics Inc are: Fmr Llc, Sekar Kathiresan, Andrew Bellinger, Burt A Adelman, 2017 Gp L.L.C. Gv, Allison Dorval, Andrew D Ashe, Krishna Yeshwant, FMR LLC, Joan Nickerson, and Bellinger Andrew
The most active insider trader at Verve Therapeutics Inc is Fmr Llc with 6 trades.
2017 Gp L.L.C. Gv has sold the most Verve Therapeutics Inc stock with a total value of $12,260,633.82.
Andrew D Ashe has bought the most Verve Therapeutics Inc stock with a total value of $1,079,920.00.
The most recent insider trade for Verve Therapeutics Inc was on May 14, 2024.
The single biggest insider buy for Verve Therapeutics Inc was from Andrew D Ashe with a total value of $475,760.00 on May 14, 2024.
The single biggest insider sell for Verve Therapeutics Inc was from Fmr Llc with a total value of $4,679,909.19 on Jan. 26, 2022.